MRI-MRS of the brain in systemic lupus erythematosus: How do we use it to understand causes of clinical signs?

Annals of the New York Academy of Sciences

Volumn 823, Issue , 1997, Pages 169-184

  Tanabe, Jody ^a   Weiner, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ISCHEMIA; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030829038     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48389.x     Document Type: Conference Paper

References (53)

1. ROTH, K. 1984. NMR-Tomography and Spectroscopy in Medicine: An Introduction. Springer-Verlag. New York.
2. ATLAS, SCOTT. 1991. Magnetic Resonance Imaging of the Brain and Spine. Raven Press. New York.
3. OSBORNE, ANNE. 1994. Diagnostic Neuroradiology. Mosby-Year Book, Inc. St. Louis.
4. LEBIHAN, D. 1995. Diffusion and Perfusion Magnetic Resonance Imaging. Raven Press. New York.
5. MOSELEY, M. et al. 1990. Early detection of regional cerebral ischemia in cats: Comparison of diffusion weighted and T2 weighted MRI and spectroscopy. Magn. Reson. Med. 14 (2):330-346.
6. ROSEN, B. R. et al. 1990. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14: 249-265.
7. KUCHARZYK, J. et al. 1993. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 188: 711-717.
8. DETRE, J. A. et al. 1992. Perfusion imaging. Magn. Reson. Med. 23: 37-45.
9. SORENSEN, A. G. et al. 1996. Mismatch of diffusion and perfusion MR imaging of acute human stroke. In Proceedings of the American Society of Neuroradiology. 34: 109. Seattle, WA.
10. LEWIN, J. S. 1996. The role of emergent perfusion/diffusion imaging of the brain in the management of acute stroke: A pilot study. In Proceedings of the American Society of Neuroradiology. Seattle, WA.
11. MINTOROVITCH, J. et al. 1991. Comparison of diffusion and T2 weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn. Reson. Med. 18 (1):39-51.
12. WEST, S. G. et al. 1995. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am. J. Med. 99 (2):153-163.
13. GONZALEZ-SCARANO, F. et al. 1979. Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann. Neurol. 5: 158-165.
14. VAN DAM, A. P. 1991. Diagnosis and pathogenesis of CNS lupus. Rheumatol. Int. 11 (1):1-11.
15. GONZALEZ-CRESPO, M. et al. 1995. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br. J. Rheumatol. 34 (11):1055-1060.
16. STIMMLER, M. M. et al. 1993. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin. Arthritis Rheum. 22 (5):335-349.
17. BAUM, K. A. et al. 1993. Systemic lupus erythematosus: Neuropsychiatric signs and symptoms related to cerebral MRI findings. Clin. Neurol. Neurosurg. 95 (1):29-34.
18. BELL, C. L. et al. 1991. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum. 34 (4):432-441.
19. KOVACS, J. A. et al. The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study. J Rheumatol. 22 (7):1247-1253.
20. RUBBERT, A. et al. 1993. SPECT analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with SLE. Arthritis Rheum. 36 (9):1253-1262.
21. EMMI, L. et al. 1993. MRI and SPECT investigations of the CNS in SLE patients. Clin. Exp. Rheumatol. 11 (1):13-20.
22. SZER, I. S. et al. 1993. Cerebral perfusion abnormalities in children with central nervous manifestations of lupus detected by single photon emission computed tomography. J. Rheumatol. 20 (12)2143-2148.
23. MILLER, D. H. et al. 1992. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J. Neurol. 239 (8):460-464.
24. BOGILD, M. D. et al. 1995. Cerebral venous sinus thrombosis and antiphospholipid antibodies. Postgrad. Med. J. 71 (838):487-489.
25. LAVERSUCH, C. J. 1995. Cerebral venous thrombosis and acquired protein S deficiency: An uncommon cause of headache in SLE. Br. J. Rheumatol. 34 (6):572-575.
26. YAMAMOTO, K. et al. 1992. SLE associated with intracranial calcification. Am. J. Neuroradiology 13: 1340-1342.
27. SALMAGGI, A. et al. 1994. Spinal cord involvement and systemic lupus erythematosus: Clinical and magnetic resonance findings in five patients. Clin. Exp. Rheumatol. 12 (4):389-394.
28. BURT, C. T. et al. 1977. Phosphorus-31 nuclear magnetic resonance detection of unexpected phosphodiesters in muscle. Biochemistry 15: 4850-4852.
29. CHALOVICH, J. M. et al. 1977. Identification of an unknown P-31 nuclear magnetic resonance from dystrophic chicken as 1-serine ethanolamine phosphodiester. Arch. Biochem. Biophys. 182: 683-689.
30. WELCH, K. M. A. et al. 1988. Brain pH in migraine: An in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalalgia 8: 273-277.
31. GLONEK, T. et al. 1982. P-31 nuclear magnetic resonance analysis of brain: The perchloric acid extract spectrum. J. Neurochem. 39: 1210-1219.
32. 31P-NMR on developing dog brain. FEBS Lett. 178: 137-142.
33. 31P MR evaluation of human brain tumor response to therapy. Magn. Reson. Med. 1: 41-42 (Abstract).
34. 31P NMR spectroscopic investigation of human neuroblastoma in situ. N. Engl. J. Med. 312: 1500-1505.
35. 31P NMR spectroscopy. Physiol. Chem. Phys. 15: 265-280.
36. 31P NMR and multiequilibria analysis. Biochemistry 20: 7399-7403.
37. 2+ in intact frog skeletal muscle. J. Biol. Chem. 255: 3987-3993.
38. 2+, MgATP, and MgADP in intact Ehrlich ascites tumor cells. Proc. Natl. Acad. Sci. U.S.A. 77: 2487-2491.
39. 2+ is associated with irreversible tissue injury after brain trauma. J. Biol. Chem. 263: 757-761.
40. 1H double resonance difference spectroscopy of the rat brain in vivo. Proc. Natl. Acad. Sci. USA 81: 6330-6334.
41. DUYN, J. H. et al. 1993. Multisection proton MR spectroscopic imaging of the brain. Radiology 188: 277-282.
42. BARKER, P. B. et al. 1995. AIDS dementia complex: Evaluation with proton MR spectroscopic imaging. Radiology 195: 58-64.
43. BARKER, P. B. et al. 1994. Acute stroke: Evaluation with serial proton MR spectroscopic imaging. Radiology 192: 723-732.
44. 1H MR spectroscopic imaging. Proceedings of the Society of Magnetic Resonance in Medicine SMR Annual Meeting. (Abstract) Nice, France.
45. PETROFF, O. A. et al. 1992. Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes. Neurology 42: 1349-1354.
46. GRIFFEY, R. H. et al. 1990. Depletion of high-energy phosphates in central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum. 33: 827-833.
47. HASELER, L. J. et al. 1991. Evaluation of neuropsychiatric systemic lupus erythematosus by volume-localized proton nuclear magnetic resonance spectroscopy. Proceedings of the Society of Magnetic Resonance in Medicine. San Francisco, CA. p. 229.
48. SIBBITT, W. L. et al. 1993. Analysis of cerebral structural changes in systemic lupus erythematosus by proton magnetic resonance spectroscopy. Clin. Res. 41: 42A (abstract).
49. DAVIE, C. A. et al. 1995. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. J. Neurol. 242: 522-528.
50. ARNOLD, D. L. 1990. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease. Magn. Reson. Med. 14: 154-159.
51. 1H spectroscopic imaging. Ann. Neurol. 36: 157-165.
52. 1H Magnetic resonance spectroscopic imaging of white matter signal hyperintensities: Alzheimer's disease and ischemic vascular dementia. Radiology 197: 517-523.
53. SIBBITT, W. L. & R. R. SIBBITT. 1993. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 19(4): 851-867.